Is topical cetirizine effective for androgenetic alopecia in women?

Hormonal hair loss, also known as androgenetic alopecia, affects millions of women worldwide. Although it has long been associated mainly with men, dermatology research now recognises that many women experience progressive hair thinning with a hormonal component—especially with age or following events like childbirth or menopause.

In the search for solutions that do not involve hormones or complex side effects, one question is gaining increasing interest: can topical cetirizine offer a real alternative for women suffering from androgenetic alopecia?

From antihistamine to potential hair treatment

Cetirizine is widely known as an oral antihistamine used to treat allergies. Recent research has begun to explore topical forms (solutions applied directly to the scalp) for hair loss. The hypothesis rests on the role that certain inflammatory processes play in the progressive miniaturization of hair follicles—a defining feature of androgenetic alopecia. Put simply, researchers propose that cetirizine may block certain inflammatory substances involved in hair loss, thereby reducing follicular weakening.

One thing to be clear about from the start: there is no approved topical cetirizine product. Regulators have licensed cetirizine as an oral antihistamine only. Every scalp solution described below was compounded for a study or made up by a pharmacy, so topical use is off-label and unregulated.

What does the evidence say?

Interest in cetirizine as a topical treatment for alopecia is relatively new, and the clinical evidence base is small. The studies that exist have enrolled both men and women, and women are often underrepresented. The most cited is a 2018 pilot study by Rossi and colleagues at Sapienza University of Rome, published in the Journal of Dermatological Treatment, which evaluated 1% topical cetirizine in androgenetic alopecia. It recruited 85 patients, of whom 67 received cetirizine and 18 served as controls. The evaluation used trichoscopic hair counts in a defined area of the scalp along with hair diameter measurements.

The authors reported an increase in total hair density, terminal hair density and hair diameter over the study period, with a fall in vellus (fine) hair density, and described the treatment as well tolerated over that period. They did not report separate results for women, so the question in this article's title is not directly answered by it. The published summary describes the controls as a placebo comparison but does not report randomization or blinding, and the study was small. It is a starting point for further research rather than a demonstration of effectiveness in women.

The one trial run specifically in women is Bassiouny and colleagues (2023, Archives of Dermatological Research, Cairo University). Sixty-six women with female-pattern hair loss were randomly assigned, double-blind, to topical cetirizine plus minoxidil or to placebo plus minoxidil for 24 weeks. Note the design: every participant received minoxidil, so the trial asks what cetirizine adds, not whether cetirizine works on its own. The authors concluded that adding cetirizine increased hair shaft thickness and produced better scores on the patients' own assessment, with side effects not significantly different between the groups — in a trial too small and short (66 women, 24 weeks) to show equal safety. Where topical cetirizine has been compared head-to-head with minoxidil in men (Hossein Mostafa et al., 2021) and in a 2022 systematic review, minoxidil did better on total hair count — so cetirizine should not be presented as an equal substitute for it.

Cetirizine and the inflammation pathway: a new angle

A noteworthy feature of cetirizine is that it does not act on hormones but on prostaglandins, a group of substances involved in inflammation. The relevant finding here comes from Garza and colleagues (2012, Science Translational Medicine), who reported that prostaglandin D2 (PGD2) is elevated in the bald scalp of men with androgenetic alopecia and inhibits hair growth. Laboratory work reports that cetirizine lowers PGD2; this is the rationale trial authors give, and no study has measured it in the scalp. The step from "lowers PGD2" to "regrows hair" has not been established, and is the reason the clinical results above still matter more than the mechanism.

User Experiences: Is Topical Cetirizine Effective for Androgenetic Alopecia in Women?

Topical cetirizine comes up in the Tressless community mainly as an add-on rather than a treatment in its own right, and members have shared a range of real-world experiences with it.

Many users describe home-made topical mixes that include cetirizine. One user reported combining cetirizine with stemoxydine and noted visible progress after eight to nine months of consistent use, alongside other actives such as minoxidil. Community members do compound their own scalp solutions from tablets and solvents; these are unregulated preparations of unknown strength, purity and sterility, and this article does not describe how it is done. Users attribute any benefit to what they describe as cetirizine's action as a prostaglandin D2 (PGD2) inhibitor — a proposed mechanism not measured in the scalp, though a personal result cannot show which ingredient in a mix did what.

In other discussions, cetirizine appeared in complex regimens that also included prescription and research compounds such as finasteride, dutasteride, estradiol and pyrilutamide. Users rarely isolate cetirizine's specific effect in these "stacks", and several of those other compounds are prescription-only or experimental and carry their own risks. Skepticism persists within the community too. Some commenters questioned the necessity of cetirizine in such regimens, especially when better-evidenced treatments like minoxidil or oral finasteride are already included.

From a broader perspective, discussions in the Tressless community often touch on the affordability and availability of cetirizine. As a common antihistamine (marketed as Zyrtec), the oral form is inexpensive and easy to obtain, and its side-effect profile as an allergy medicine is well documented. Topical use remains off-label, and community members report choosing it to avoid hormonal treatments — a preference, not a demonstrated safety advantage, since the long-term effects of applying cetirizine to the scalp have not been studied.

Very few users report using cetirizine as a standalone treatment. Those who did typically noted modest results, and describe it as a secondary agent rather than a primary one. In summary, community reports point to topical cetirizine being used as one component of a broader regimen, with users describing its contribution as supportive rather than transformative. These are anecdotes, not trial results, and they cannot establish whether the treatment works.

Specific trials in women: what we still need to know

Most studies of cetirizine have included women in their samples without analysing them as a separate group, and only one randomized trial (Bassiouny 2023) has been run in women alone — and that one tested cetirizine as an add-on to minoxidil. What is missing is a larger, randomized, double-blind trial of topical cetirizine on its own in women with androgenetic alopecia, with results published rather than announced. Until such a study reports, the honest position is that the effectiveness of topical cetirizine in women is unproven.

How is it applied and what are the risks?

In the published studies, 1% topical cetirizine was applied to the scalp once daily (one trial used it twice daily). Systemic side effects were not commonly reported in these short studies, though they ran for six months or less and were too small to detect uncommon harms. Some individuals may experience mild irritation or itching at the application site. Because cetirizine does not act on hormones, some women who cannot or prefer not to use hormonal treatments look at it as an alternative — but "not hormonal" is not the same as "proven" or "risk-free", and minoxidil remains the only topical treatment approved for female-pattern hair loss.

Talk to a doctor or pharmacist before starting, stopping or combining topical cetirizine, particularly if you are pregnant, breastfeeding, or already using minoxidil or a prescription anti-androgen — and get a diagnosis first, because several treatable conditions cause hair thinning that looks like androgenetic alopecia.

Current evidence suggests topical cetirizine is worth studying further in women with androgenetic alopecia. The studies so far are small, mostly mixed-sex, and the only trial in women alone tested it as an add-on to minoxidil. Its interest lies in acting through a different pathway from established treatments, which could matter for patients who do not respond well to them. On the evidence available, topical cetirizine is an off-label, unproven option rather than an established treatment for hormonally driven hair loss in women.

References

Rossi, A., Campo, D., Fortuna, M. C., Garelli, V., Pranteda, G., De Vita, G., Sorriso-Valvo, L., Di Nunno, D., & Carlesimo, M. (2018). A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia. Journal of Dermatological Treatment, 29(2), 149-151. https://pubmed.ncbi.nlm.nih.gov/28604133/

Bassiouny, E. A., El-Samanoudy, S. I., Abbassi, M. M., Nada, H. R., & Farid, S. F. (2023). Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study. Archives of Dermatological Research, 315(5), 1293-1304. https://pubmed.ncbi.nlm.nih.gov/36571611/

Hossein Mostafa, D., Samadi, A., Niknam, S., Nasrollahi, S. A., Guishard, A., & Firooz, A. (2021). Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study. Journal of Pharmacy & Pharmaceutical Sciences. https://pubmed.ncbi.nlm.nih.gov/33909554/

Chen, X., Xiang, H., & Yang, M. (2022). Topical cetirizine for treating androgenetic alopecia: A systematic review. Journal of Cosmetic Dermatology. https://pubmed.ncbi.nlm.nih.gov/35976065/

Garza, L. A., Liu, Y., Yang, Z., Alagesan, B., Lawson, J. A., et al. (2012). Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia. Science Translational Medicine, 4(126), 126ra34. https://pubmed.ncbi.nlm.nih.gov/22440736/